Acarbose 25 mg Australia

Description

Introduction

Acarbose 25 mg Australia is presented as a tablet containing 25 mg of acarbose. Acarbose is used in the management of type 2 diabetes. It slows carbohydrate digestion in the gut and can reduce the rise in blood glucose after a meal.

The inactive ingredients and Australian registration status of this exact product are not established here. People who need those details, particularly because of an allergy, should ask a pharmacist or another healthcare professional.

What Is It?

Acarbose belongs to a group of medicines called alpha-glucosidase inhibitors. The product is presented in tablet form, with 25 mg of active ingredient per tablet. The stated strength describes the tablet; it does not establish how much any person should take.

For type 2 diabetes, acarbose may be considered as part of a plan that also includes food choices, physical activity and blood glucose monitoring. A healthcare professional determines whether it is appropriate alongside other treatments.

How Does It Work?

Enzymes in the digestive tract break down starches and certain sugars into smaller sugars that the body can absorb. Acarbose inhibits enzymes involved in this process. Glucose is absorbed more slowly, reducing the rise in blood glucose that can follow a carbohydrate-containing meal.

This action does not remove carbohydrates from the diet or replace other diabetes care. Undigested carbohydrates can pass into the lower gut, which helps explain why wind, bloating and diarrhoea may occur.

Common Uses

Acarbose is used to help manage blood glucose in type 2 diabetes when diet and exercise alone do not provide adequate control. A clinician may also use it with other glucose-lowering medicines when combination treatment is appropriate.

Its particular role concerns blood glucose after meals. Acarbose is not a treatment for type 1 diabetes or diabetic ketoacidosis. Ask a healthcare professional for guidance about the indication and status of this exact 25 mg product.

Available Strengths

This family is available in 25 mg, 50 mg.

Key Features

• Tablet product presented with 25 mg of acarbose per tablet.
• Alpha-glucosidase inhibitor that acts mainly in the digestive tract.
• Delays the digestion and absorption of some dietary carbohydrates.
• Addresses blood glucose rises following meals containing carbohydrate.
• Can be assessed as one component of a type 2 diabetes care plan.

Benefits

• Acarbose can reduce post-meal blood glucose in people with type 2 diabetes.
• Clinical studies have also found improvements in HbA1c, a measure of longer-term blood glucose control.
• Its mechanism differs from medicines that stimulate insulin release, giving clinicians another approach to blood glucose management.
• The effect varies between individuals and can be assessed through blood glucose monitoring and clinical follow-up.

Possible Side Effects

• Wind, abdominal rumbling, bloating, discomfort and diarrhoea are common digestive effects, especially early in treatment.
• Nausea, indigestion and softer stools can also occur. Persistent symptoms should be discussed with a healthcare professional.
• Low blood glucose may occur when acarbose is combined with insulin or a sulfonylurea.
• Uncommon but serious problems include liver injury, bowel obstruction and allergic reactions. Severe abdominal symptoms, yellowing of the skin or eyes, or signs of a serious allergic reaction need prompt medical assessment.

Precautions

• A history of inflammatory bowel disease, bowel obstruction or significant digestive or absorption problems requires medical review before use.
• Severe kidney disease may affect whether acarbose is appropriate.
• Liver disease or abnormal liver tests should be discussed with a healthcare professional. Liver monitoring may be considered during treatment.
• Acarbose should not be used by someone with a known allergy to acarbose. The inactive ingredients of this exact tablet need to be checked separately.

Additional Precautions

• Pregnancy, plans for pregnancy and breastfeeding call for a review of the diabetes treatment plan with a healthcare professional.
• Acarbose does not treat diabetic ketoacidosis, which requires urgent medical care.
• When acarbose is combined with insulin or a sulfonylurea, glucose or dextrose is used to treat low blood glucose because acarbose delays the breakdown of table sugar.
• Illness, infection and surgery can affect blood glucose control. Treatment may need professional review during these periods.

Storage Instructions

• Follow the storage directions on the supplied packaging, or ask a pharmacist about this exact product.
• Keep the tablets protected from moisture and out of the reach of children.
• Check the labelled expiry date before use and ask a pharmacist about tablets from damaged packaging.
• A precise storage temperature for this exact 25 mg product has not been verified.

How to Take

• Follow the directions given for the prescribed treatment. The tablet strength alone does not determine an individual regimen.
• Acarbose is generally used in connection with meals so its action coincides with carbohydrate digestion. Follow the instructions supplied with this exact product.
• Ask a pharmacist or prescriber what to do about a missed dose or any proposed change to treatment.
• Continue the food, activity and blood glucose monitoring plan recommended by the treating clinician.

Drug Interactions

• Insulin and sulfonylureas can increase the risk of low blood glucose when used with acarbose.
• Digestive enzyme preparations and intestinal adsorbents, including activated charcoal, may reduce acarbose’s effect.
• Acarbose can alter digoxin exposure. A clinician may need to review monitoring if both medicines are used.
• Medicines that raise blood glucose, including corticosteroids and some diuretics, can affect overall diabetes control.
• A pharmacist or prescriber should be told about prescription medicines, non-prescription products and supplements being used.

Why Choose This Product?

• It presents acarbose as a 25 mg tablet for consideration within an individualised treatment plan.
• Acarbose has an established action on meal-related blood glucose rises.
• Its effect and tolerability can be reviewed through monitoring and clinical follow-up.
• Product-specific ingredients, suitability and Australian registration status should be checked with a healthcare professional.

Frequently Asked Questions (FAQs)

What is the active ingredient?

The product is presented with acarbose as its active ingredient, at 25 mg per tablet.

What is the dosage form?

It is presented as a tablet. Its appearance and inactive ingredients have not been confirmed.

What condition is acarbose used for?

Acarbose is used to help manage blood glucose in type 2 diabetes.

Does it replace diet and exercise?

No. Food choices, physical activity and monitoring remain part of diabetes care.

Does it mainly affect blood glucose after meals?

Yes. It delays carbohydrate digestion, so its direct effect is on the rise after a meal.

Can acarbose cause low blood glucose?

The risk is greater when it is combined with insulin or a sulfonylurea.

What side effects are most common?

Wind, bloating, abdominal discomfort and diarrhoea are common.

Can it be used during pregnancy?

Diabetes treatment during pregnancy needs individual medical review.

Are this tablet’s inactive ingredients known?

They have not been confirmed for this exact product. Ask a pharmacist if an allergy is relevant.

Is this exact product registered in Australia?

Its Australian registration status has not been established. Ask a healthcare professional for product-specific guidance.

Related Products

• Acarbose 25 mg Australia
• Acarbose 50 mg Australia
• Glimepiride 3 mg Australia
• Voglibose 0.2 mg Australia
• Miglitol 50 mg Australia
• Repaglinide 1 mg Australia